Skip to Main Content

Paper Details

Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.
Circulation
4
2023
DELIVER, Dapagliflozin, HF, Heart Failure, Mildly Reduced and Preserved Ejection Fraction Heart Failure, Patients, cardiovascular, cardiovascular death, dapagliflozin, heart failure, patient, patients
Author NameAffiliation
Akshay S DesaiBrigham and Women's Hospital, Harvard Medical School
Rudolf A de BoerErasmus Medical Center
Adrian F HernandezDuke University Medical Center
Mikhail KosiborodSaint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.N.K.).
Carolyn S P LamNational Heart Centre Singapore & Duke-National University of Singapore (C.S.P.L.).
  • 1 - 5

Datasets

Release 1.2